Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Receiving Immune Checkpoint Inhibitors, With Deep Phenotyping and Multi-Omics Biomarker Discovery

NCT07357636 is registered in ClinicalTrials.gov with Shantou University Medical College as lead sponsor.

NCT NCT07357636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07357636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Receiving Immune Checkpoint Inhibitors, With Deep Phenotyping and Multi-Omics Biomarker Discovery
Lead sponsor
Shantou University Medical College
Phase
Observational
Overall status
Recruiting
Start date
January 10, 2019
Completion date
September 10, 2029
Enrollment
940 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

immune-related adverse events, immunotherapy toxicity, solid tumor